US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 81.610
  • -0.560-0.68%
Trading Apr 26 13:18 ET
15.49BMarket Cap76.99P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-42.24%175.9M
-39.30%6.79M
63.12%158.32M
-32.08%56.23M
Net income from continuing operations
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
113.77%27.66M
Operating gains losses
-207.99%-20.8M
123.26%28.45M
478.41%10.34M
46.53%-2M
115.42%840K
116.77%19.27M
-6,656.19%-122.29M
486.18%1.79M
-990.96%-3.74M
-9.93%-5.45M
Depreciation and amortization
3.52%27.35M
2.37%104.39M
9.40%26.86M
3.56%25.69M
0.59%25.42M
-3.37%26.42M
-5.62%101.97M
-5.51%24.55M
-7.59%24.8M
-7.20%25.27M
Deferred tax
104.48%285K
13.64%-44.98M
51.61%-24.84M
-258.00%-15.03M
193.09%1.25M
-232.50%-6.36M
-233.72%-52.09M
-1,330.99%-51.34M
68.25%-4.2M
36.88%-1.35M
Other non cash items
38.41%1.12M
1.19%3.82M
199.41%849K
-55.60%555K
574.12%1.61M
-78.32%807K
-60.41%3.78M
-157.24%-854K
-32.69%1.25M
-109.03%-340K
Change In working capital
51.35%-105.39M
-249.17%-336.54M
-638.86%-97.12M
-56.39%39.92M
-64.68%-62.7M
-58.49%-216.64M
-245.96%-96.38M
-11,231.03%-13.14M
34.60%91.53M
-276.30%-38.07M
-Change in receivables
97.56%-3.39M
-132.14%-190.44M
-106.83%-58.5M
-64.21%13.89M
81.36%-7.04M
-153.22%-138.8M
-225.10%-82.03M
-46,462.30%-28.28M
-19.30%38.81M
-65.03%-37.75M
-Change in inventory
-19.31%-16.82M
-130.07%-157.06M
-44.72%-59.11M
-59.58%-41.47M
-1,557.98%-42.38M
-1,353.16%-14.1M
-94.71%-68.26M
-156.32%-40.85M
-1.90%-25.99M
-119.96%-2.56M
-Change in payables and accrued expense
-86.22%-59.01M
16.66%68.85M
-79.61%12.52M
10.11%81.43M
266.69%6.59M
59.45%-31.69M
276.17%59.02M
169.16%61.42M
37.56%73.95M
-84.26%1.8M
-Change in other current assets
18.83%-29.48M
-576.95%-81.48M
91.79%-1.28M
-428.80%-21.16M
-710.97%-22.72M
-452.79%-36.32M
-151.96%-12.04M
-352.07%-15.62M
180.12%6.43M
138.15%3.72M
-Change in other current liabilities
-22.36%3.31M
240.18%23.59M
-9.16%9.25M
531.32%7.23M
186.49%2.84M
149.24%4.26M
307.82%6.93M
382.52%10.19M
-430.38%-1.68M
-91.16%-3.29M
Cash from discontinued investing activities
Operating cash flow
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-42.24%175.9M
-39.30%6.79M
63.12%158.32M
-32.08%56.23M
Investing cash flow
Cash flow from continuing investing activities
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
94.53%-20.03M
1.28%-54.71M
80.47%-23.4M
75.30%-29.7M
Net PPE purchase and sale
-6.74%-26.1M
20.06%-96.69M
18.97%-28.92M
25.82%-21.74M
20.52%-21.58M
15.13%-24.46M
-26.56%-120.96M
-24.18%-35.69M
-56.40%-29.3M
-20.16%-27.15M
Net intangibles purchase and sale
-2,480.65%-8M
-3.20%-10.92M
-1,059.31%-7.78M
76.52%-1.68M
-30.19%-1.15M
83.32%-310K
55.25%-10.58M
95.70%-671K
-341.02%-7.17M
75.88%-881K
Net investment purchase and sale
288.11%9.87M
-144.38%-3.63M
-142.09%-28.27M
-271.24%-22.38M
3,240.63%52.26M
-162.03%-5.25M
103.33%8.19M
-5.55%-11.68M
113.15%13.07M
98.21%-1.66M
Net other investing changes
--10M
----
----
----
----
----
10,494.87%103.33M
---6.68M
--0
--0
Cash from discontinued investing activities
Investing cash flow
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
94.53%-20.03M
1.28%-54.71M
80.47%-23.4M
75.30%-29.7M
Financing cash flow
Cash flow from continuing financing activities
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
-38,754.17%-18.65M
-24.50%10.87M
831.43%7.54M
-207.57%-11.78M
Net issuance payments of debt
95.86%-42K
12.25%-2.29M
95.36%-45K
-18.13%-606K
-11.69%-621K
-79.15%-1.01M
14.28%-2.61M
-77.33%-970K
6.90%-513K
35.12%-556K
Proceeds from stock option exercised by employees
-66.00%7.2M
0.03%69.35M
-41.87%14.81M
-69.70%4.36M
36.53%29.02M
157.06%21.17M
40.94%69.33M
56.08%25.47M
174.45%14.37M
-2.59%21.26M
Net other financing activities
17.98%-49.95M
-0.49%-85.79M
71.24%-3.92M
28.20%-4.54M
49.39%-16.44M
-84.82%-60.9M
-84.79%-85.38M
-891.85%-13.63M
-10.53%-6.32M
-224.33%-32.48M
Cash from discontinued financing activities
Financing cash flow
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
-38,754.17%-18.65M
-24.50%10.87M
831.43%7.54M
-207.57%-11.78M
Net cash flow
Beginning cash position
4.22%755.13M
23.37%724.53M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
23.37%724.53M
-9.53%587.28M
23.39%761.52M
-3.39%619.8M
-9.27%605.44M
Current changes in cash
93.05%-10.06M
-78.66%29.29M
28.11%-26.64M
-37.48%89.06M
656.46%111.56M
-947.55%-144.69M
321.95%137.22M
-24.16%-37.06M
698.12%142.46M
155.60%14.75M
Effect of exchange rate changes
741.48%1.93M
3,987.50%1.31M
-5,236.62%-3.65M
364.26%1.97M
814.81%2.75M
-79.05%229K
156.14%32K
422.73%71K
-30.59%-747K
-151.89%-385K
End cash Position
28.78%747M
4.22%755.13M
4.22%755.13M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
23.37%724.53M
23.37%724.53M
23.39%761.52M
-3.39%619.8M
Free cash flow
113.04%12.87M
16.42%51.65M
68.85%-9.21M
-7.90%112.23M
67.90%47.33M
-29.68%-98.7M
-76.06%44.36M
10.87%-29.57M
58.87%121.85M
-50.13%28.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M-42.24%175.9M-39.30%6.79M63.12%158.32M-32.08%56.23M
Net income from continuing operations 74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M113.77%27.66M
Operating gains losses -207.99%-20.8M123.26%28.45M478.41%10.34M46.53%-2M115.42%840K116.77%19.27M-6,656.19%-122.29M486.18%1.79M-990.96%-3.74M-9.93%-5.45M
Depreciation and amortization 3.52%27.35M2.37%104.39M9.40%26.86M3.56%25.69M0.59%25.42M-3.37%26.42M-5.62%101.97M-5.51%24.55M-7.59%24.8M-7.20%25.27M
Deferred tax 104.48%285K13.64%-44.98M51.61%-24.84M-258.00%-15.03M193.09%1.25M-232.50%-6.36M-233.72%-52.09M-1,330.99%-51.34M68.25%-4.2M36.88%-1.35M
Other non cash items 38.41%1.12M1.19%3.82M199.41%849K-55.60%555K574.12%1.61M-78.32%807K-60.41%3.78M-157.24%-854K-32.69%1.25M-109.03%-340K
Change In working capital 51.35%-105.39M-249.17%-336.54M-638.86%-97.12M-56.39%39.92M-64.68%-62.7M-58.49%-216.64M-245.96%-96.38M-11,231.03%-13.14M34.60%91.53M-276.30%-38.07M
-Change in receivables 97.56%-3.39M-132.14%-190.44M-106.83%-58.5M-64.21%13.89M81.36%-7.04M-153.22%-138.8M-225.10%-82.03M-46,462.30%-28.28M-19.30%38.81M-65.03%-37.75M
-Change in inventory -19.31%-16.82M-130.07%-157.06M-44.72%-59.11M-59.58%-41.47M-1,557.98%-42.38M-1,353.16%-14.1M-94.71%-68.26M-156.32%-40.85M-1.90%-25.99M-119.96%-2.56M
-Change in payables and accrued expense -86.22%-59.01M16.66%68.85M-79.61%12.52M10.11%81.43M266.69%6.59M59.45%-31.69M276.17%59.02M169.16%61.42M37.56%73.95M-84.26%1.8M
-Change in other current assets 18.83%-29.48M-576.95%-81.48M91.79%-1.28M-428.80%-21.16M-710.97%-22.72M-452.79%-36.32M-151.96%-12.04M-352.07%-15.62M180.12%6.43M138.15%3.72M
-Change in other current liabilities -22.36%3.31M240.18%23.59M-9.16%9.25M531.32%7.23M186.49%2.84M149.24%4.26M307.82%6.93M382.52%10.19M-430.38%-1.68M-91.16%-3.29M
Cash from discontinued investing activities
Operating cash flow 163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M-42.24%175.9M-39.30%6.79M63.12%158.32M-32.08%56.23M
Investing cash flow
Cash flow from continuing investing activities 52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M94.53%-20.03M1.28%-54.71M80.47%-23.4M75.30%-29.7M
Net PPE purchase and sale -6.74%-26.1M20.06%-96.69M18.97%-28.92M25.82%-21.74M20.52%-21.58M15.13%-24.46M-26.56%-120.96M-24.18%-35.69M-56.40%-29.3M-20.16%-27.15M
Net intangibles purchase and sale -2,480.65%-8M-3.20%-10.92M-1,059.31%-7.78M76.52%-1.68M-30.19%-1.15M83.32%-310K55.25%-10.58M95.70%-671K-341.02%-7.17M75.88%-881K
Net investment purchase and sale 288.11%9.87M-144.38%-3.63M-142.09%-28.27M-271.24%-22.38M3,240.63%52.26M-162.03%-5.25M103.33%8.19M-5.55%-11.68M113.15%13.07M98.21%-1.66M
Net other investing changes --10M--------------------10,494.87%103.33M---6.68M--0--0
Cash from discontinued investing activities
Investing cash flow 52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M94.53%-20.03M1.28%-54.71M80.47%-23.4M75.30%-29.7M
Financing cash flow
Cash flow from continuing financing activities -5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M-38,754.17%-18.65M-24.50%10.87M831.43%7.54M-207.57%-11.78M
Net issuance payments of debt 95.86%-42K12.25%-2.29M95.36%-45K-18.13%-606K-11.69%-621K-79.15%-1.01M14.28%-2.61M-77.33%-970K6.90%-513K35.12%-556K
Proceeds from stock option exercised by employees -66.00%7.2M0.03%69.35M-41.87%14.81M-69.70%4.36M36.53%29.02M157.06%21.17M40.94%69.33M56.08%25.47M174.45%14.37M-2.59%21.26M
Net other financing activities 17.98%-49.95M-0.49%-85.79M71.24%-3.92M28.20%-4.54M49.39%-16.44M-84.82%-60.9M-84.79%-85.38M-891.85%-13.63M-10.53%-6.32M-224.33%-32.48M
Cash from discontinued financing activities
Financing cash flow -5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M-38,754.17%-18.65M-24.50%10.87M831.43%7.54M-207.57%-11.78M
Net cash flow
Beginning cash position 4.22%755.13M23.37%724.53M3.14%785.41M12.03%694.38M-4.19%580.07M23.37%724.53M-9.53%587.28M23.39%761.52M-3.39%619.8M-9.27%605.44M
Current changes in cash 93.05%-10.06M-78.66%29.29M28.11%-26.64M-37.48%89.06M656.46%111.56M-947.55%-144.69M321.95%137.22M-24.16%-37.06M698.12%142.46M155.60%14.75M
Effect of exchange rate changes 741.48%1.93M3,987.50%1.31M-5,236.62%-3.65M364.26%1.97M814.81%2.75M-79.05%229K156.14%32K422.73%71K-30.59%-747K-151.89%-385K
End cash Position 28.78%747M4.22%755.13M4.22%755.13M3.14%785.41M12.03%694.38M-4.19%580.07M23.37%724.53M23.37%724.53M23.39%761.52M-3.39%619.8M
Free cash flow 113.04%12.87M16.42%51.65M68.85%-9.21M-7.90%112.23M67.90%47.33M-29.68%-98.7M-76.06%44.36M10.87%-29.57M58.87%121.85M-50.13%28.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg